Find uplifting stories about heroes, innovations, and solutions
12694 results for "immunotherapy breakthrough"
Actor Sam Neill has no detectable cancer after switching to CAR T-cell therapy when traditional chemotherapy stopped working. The 78-year-old Jurassic Park star is calling his latest scan results "extraordinary."
After four months of immunotherapy infusions, a 71-year-old woman's esophageal cancer vanished completely without surgery, chemotherapy, or radiation. Scientists say these breakthrough treatments are finally hitting their stride after nearly 100 years of development.
Japanese researchers discovered that widely prescribed statin drugs could help cancer immunotherapy work better by blocking tumors' ability to suppress the immune system. The breakthrough offers hope for millions since statins are already safe, affordable, and available worldwide.
Scientists discovered how lung tumors hijack the body's immune safety system to protect themselves from treatment. The breakthrough could help immunotherapy work for thousands more cancer patients.
Scientists discovered that making cancer cells physically stiffer dramatically improved CAR T-cell therapy results in mice with severe skin cancer. This breakthrough could help save more lives by making one of medicine's most promising cancer treatments even more effective.
Researchers accidentally discovered a protein that appears only on cancer cells, not healthy tissue. This breakthrough could help doctors create more precise cancer treatments with fewer side effects.
After nearly a century of research, immunotherapy treatments are curing some cancers without surgery, chemotherapy, or radiation. Patients like 71-year-old Maureen Sideris are seeing tumors disappear after just months of treatment.
After 12 years and multiple melanoma diagnoses, Joe Eastin faced his toughest challenge when the cancer spread to his bones. Cutting-edge immunotherapy shrank his tumor by 50% in just three months.
A groundbreaking treatment just became available to thousands of European women whose ovarian cancer stopped responding to standard chemotherapy. The approval marks the first time an immunotherapy has been authorized in the EU for this hard-to-treat condition.
A $50,000 grant is helping Canadian researchers unlock why the deadliest brain cancer resists treatment that works for other cancers. The early-stage work could lead to the first effective immunotherapy for glioblastoma patients.
A young woman with advanced colorectal cancer is now cancer-free after receiving a groundbreaking dual immunotherapy treatment that took just four months. She even ran a 5K during treatment, avoiding the debilitating side effects of traditional chemotherapy.
Saudi Arabia just became the first country in the world to approve Anktiva, a groundbreaking immunotherapy for advanced lung cancer patients who've run out of options. The treatment gives new hope to patients whose disease has progressed despite standard therapies.
Scientists discovered that timing might unlock immunotherapy for the 85% of colon cancer patients whose tumors don't respond to current immune treatments. Early results show 26% of these previously resistant tumors responded when treated before surgery instead of after.
Scientists discovered how cancer cells hide from cutting-edge immunotherapy and used an existing drug to make the treatment work again. Six patients whose immune cell therapy had stopped working saw their cancer respond once more.
Chinese researchers have perfected a way to bond two critical fusion reactor materials, bringing us closer to clean, unlimited energy. The breakthrough solves a major engineering challenge that has limited fusion reactor development.
The Cancer Research Institute launched a patient resource hub connecting cancer patients with immunotherapy information and clinical trials. The platform features survivor stories and treatment guidance for those exploring cutting-edge cancer care options.
A groundbreaking immunotherapy has been registered in South Africa to treat a rare and aggressive head and neck cancer that often goes undiagnosed until advanced stages. The treatment harnesses the body's own immune system to fight cancer, offering new hope for patients with nasopharyngeal carcinoma.
A breakthrough trial shows that just nine weeks of immunotherapy before surgery has kept every colorectal cancer patient in the study cancer-free for nearly three years. The approach challenges decades of standard treatment and could change care for thousands of patients annually.
Cancer doctors are discovering that nurturing gut bacteria, instead of destroying it with antibiotics, could dramatically improve survival rates for patients undergoing treatment. A nationwide trial is now testing probiotics to boost immunotherapy effectiveness.
The internet, electric cars, and 13 other world-changing technologies were laughed at, rejected, or dismissed before they transformed our lives. History shows that breakthrough ideas often look impractical until the world catches up.
Showing 20 of 12694